HLA class II DR-DQ and increased risk of cervical cancer among senegalese women

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 10, 2001, Pages 1037-1045

  Kiviat, Nancy B ^a,b   Lin, Patricia ^a   Koutsky, Laura A ^a   Critchlow, Cathy W ^a   Hawes, Stephen E ^a   Hughes, James P ^b   Apple, Raymond J ^c   Touré, Papa ^d   Dembele, Amadou ^d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ROCHE MOLECULAR SYSTEMS   (United States)

^d Dantec Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CELLULAR IMMUNITY; ETHNIC GROUP; FEMALE; HAPLOTYPE; HIGH RISK POPULATION; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; SENEGAL; UTERINE CERVIX CANCER;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; GENES, MHC CLASS II; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ ANTIGENS; HLA-DR2 ANTIGEN; HUMANS; INCIDENCE; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; REFERENCE VALUES; RISK ASSESSMENT; SAMPLING STUDIES; SENEGAL; UTERINE CERVICAL NEOPLASMS;

EID: 0034791741     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Epidemiological evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia
2. Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women
3. Estimates of the worldwide frequency of sixteen major cancers in 1980
4. A brief synopsis of the role of human papillomaviruses in cervical carcinogenesis
5. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
6. Human Papillomaviruses
7. Natural history of cervical neoplasia: Overview and update
8. Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles
9. HLA DQ-DR haplotype and susceptibility to cervical carcinoma: Indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18
10. HLA-DQB1*03 and cervical intraepithelial neoplasia type III
11. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3
12. Role of human papillomavirus in determining the HLA associated risk of cervical carcinogenesis
13. Association of human leukocyte antigen-B1*03 with cervical cancer in Japanese women aged 35 years and younger
14. DQA1 and DQB1 genes in patients with squamous cell carcinoma of the cervix: Relationship to human papillomavirus infection and prognosis
15. Cervical carcinoma: Human papillomavirus infection and HLA-associated risk factors in the Spanish population
16. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: Results from a case-control study conducted in the United States
17. Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women
18. HLA and susceptibility to cervical neoplasia
19. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity
20. Decreased frequency of HLA-DRB1*13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix
21. HLA types in women with cervical human papillomavirus (HPV) lesions prospectively followed up for 10 years
22. Genetic features of Mexican women predisposing to cancer of the uterine cervix
23. Association between HLA DQB1*03 and cervical intra-epithelial neoplasia
24. Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer
25. Cervical intraepithelial neoplasia, cervical carcinoma, and risk for patients with HLA-DQB1*0602,*301,*0303 alleles
26. DRw11 haplotypes: Continuum of DRB1 diversity augmented by unique DQ/DRw52 associations
27. Epidemiology of genital human papillomavirus infection
28. Determinants of genital human papillomavirus infection in low-income women in Washington, D.C
29. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon
30. Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico Student Health Center
31. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent
32. Colposcopic appearance of cervical intraepithelial neoplasia is age dependent
33. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method
34. Analysis of HLA class II polymorphism using polymerase chain reaction
35. Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes
36. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region
37. Cervical intraepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV-1 or HIV-2 or seronegative for HIV
38. Anatomy and histology of the cervix
39. Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women
40. Association between DQB1 and cervical cancer in patients with human papillomavirus and family controls
41. Immunogenetic factors in HPV-associated cervical cancer: Influence on disease progression
42. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women
43. HLA-DR polymorphism in a Senegalese Mandenka population: DNA oligotyping and population genetics of DRB1 specificities
44. Extensive genetic diversity in the HLA class II region of Africans, with a focally predominant allele, DRB1*1304
45. HLA class II specificities and haplotypes in South Africa detected using polymerase chain reaction and sequence-specific oligonucleotide typing
46. Do HPV negative carcinomas exist?
47. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
48. Do HPV-negative cervical carcinomas exist? - Revisited
49. HLA control in the progression of human papillomavirus infections
50. HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection
51. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance
52. The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma
53. HLA class II antigen expression in human papillomavirus-associated cervical cancer
54. Specific HLA class I down-regulation is an early event in cervical dysplasia associated with clinical progression
55. Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer
56. Multiple mechanisms underlie HLA dysregulation in cervical cancer